亚宝药业：关于控股股东股票质押式回购交易股份提前购回的公告

Core Points - On September 29, 2025, the company announced that its controlling shareholder, Yabao Investment, received a notice of pledge release [1] - Yabao Investment repurchased 13,650,000 unrestricted circulating shares that were pledged to Shanxi Securities Co., Ltd. through a stock pledge repurchase transaction [1] - Following the completion of the repurchase transaction, the corresponding shares' pledge was released [1]